Literature DB >> 8955916

Plasma and cerebrospinal fluid hyperinsulinism in asphyxiated piglets.

C S Abrahám1, P Temesvári, J Kovács, K Schultz, D Molnár.   

Abstract

Insulin (I) plays a crucial role in the maturation of the perinatal brain, and it may also be involved in the pathogenesis of neonatal brain injuries. The aim of the present study was to reveal the effect of neonatal asphyxia on the regulation of I and glucose (G) metabolism in plasma and cerebrospinal fluid (CSF) in newborn piglets. The I concentrations were measured by radioimmunoassay, while the G levels were analyzed by the G oxidase method during three phases (basal, critical, recovery) of bilateral pneumothorax in newborn piglets. We observed a significant hyperinsulinism (p < 0.001) both in plasma and CSF and a mild hypoglycemia (p < 0.05) during the recovery period. Postasphyxial G infusion (1.1 M, 10 ml.kg-1) amplified the hyperinsulinism. The ICSF/plasma ratio (mean +/- SEM; n = 16) was decreasing during cardiovascular failure (0.09 +/- 0.02; NS) as compared with the initial value (0.12 +/- 0.04), then it returned to basal values by 60 min (0.14 +/- 0.04; NS), and increased significantly 180 min (0.40 +/- 0.14; p < 0.05) after resuscitation of the piglets. There was a similar increase in GCSF/plasma ratio in asphyxiated animals at the end of experiments (0.99 +/- 0.15 vs. initial 0.76 +/- 0.05; p < 0.05). In conclusion, neonatal asphyxia resulted in plasma and CSF hyperinsulinism which may alter hypoxic-ischemic cerebral damages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955916     DOI: 10.1159/000244379

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  1 in total

1.  Vascular changes play a role in the pathogenesis of necrotizing enterocolitis in asphyxiated newborn pigs.

Authors:  B Gellén; J Kovács; L Németh; P Németh; J Vágvölgyi; F Bari; P Megyeri; S Pintér; P Temesvári; M A Deli; M Vecsernyés; Z Szilvássy; M Koltai; C S Abrahám
Journal:  Pediatr Surg Int       Date:  2003-05-20       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.